Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105930947 | 10593094 | 7 | F | 2011 | 20160829 | 20141119 | 20160908 | EXP | US-JNJFOC-20141105044 | JANSSEN | 0.00 | C | M | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105930947 | 10593094 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | N | U | 0 | UNSPECIFIED | ||||||||
| 105930947 | 10593094 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | N | U | 0 | UNSPECIFIED | ||||||||
| 105930947 | 10593094 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | N | U | 0 | UNSPECIFIED | ||||||||
| 105930947 | 10593094 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | N | U | 0 | UNSPECIFIED | ||||||||
| 105930947 | 10593094 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | N | U | 0 | UNSPECIFIED | ||||||||
| 105930947 | 10593094 | 6 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | N | U | 20272 | UNSPECIFIED | ||||||||
| 105930947 | 10593094 | 7 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 105930947 | 10593094 | 8 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 20272 | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105930947 | 10593094 | 1 | Depression |
| 105930947 | 10593094 | 2 | Depression |
| 105930947 | 10593094 | 3 | Obsessive-compulsive disorder |
| 105930947 | 10593094 | 4 | Obsessive-compulsive disorder |
| 105930947 | 10593094 | 5 | Bipolar disorder |
| 105930947 | 10593094 | 6 | Bipolar disorder |
| 105930947 | 10593094 | 7 | Product used for unknown indication |
| 105930947 | 10593094 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105930947 | 10593094 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105930947 | 10593094 | Blood cholesterol increased | |
| 105930947 | 10593094 | Blood triglycerides increased | |
| 105930947 | 10593094 | Diabetic neuropathy | |
| 105930947 | 10593094 | Emotional distress | |
| 105930947 | 10593094 | Gynaecomastia | |
| 105930947 | 10593094 | Obesity | |
| 105930947 | 10593094 | Type 2 diabetes mellitus | |
| 105930947 | 10593094 | Type V hyperlipidaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105930947 | 10593094 | 2 | 1995 | 2008 | 0 | |
| 105930947 | 10593094 | 4 | 1995 | 2008 | 0 | |
| 105930947 | 10593094 | 5 | 1995 | 2008 | 0 | |
| 105930947 | 10593094 | 7 | 2009 | 2012 | 0 |